Cover is for reference only

Handbook of hypertension

When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated c.

Saved in:
Bibliographic Details
Main Authors: Houston, Mark C.
Corporate Authors: Wiley InterScience (Online service)
Published:
Literature type: eBook
Language: English
Subjects:
Hypertension > Handbooks, manuals, etc.
MEDICAL > Cardiology.
Hypertension.
Hypertension > Handbooks.
Antihypertensive Agents > Handbooks > therapeutic use.
Hypertension > Handbooks > drug therapy.
Electronic books.
Electronic resource.
Handbooks and manuals.
Online Access: http://onlinelibrary.wiley.com/book/10.1002/9781444311808
Summary: When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated c.
Carrier Form: 1 online resource (x, 402 p.) : ill.
Bibliography: Includes bibliographical references (p. 375-391) and index.
ISBN: 9781444311808
1444311808
9781444311792 (electronic bk.)
1444311794 (electronic bk.)
1405182504 (pbk.)
9781405182508 (pbk.)
Index Number: RC685
CLC: R544.1-62
Contents: Cover -- Contents -- Abbreviations -- Part 1 General Introduction to Hypertension -- Hypertension Prevalence and Consequences -- Hypertension Syndrome -- Subsets of Hypertension Approach to Treatment -- Clinical Hypertension Trials: A Perspective -- Vascular Biology and Hypertension -- Blood Vessel Structure -- Endothelial Function and Dysfunction -- New Treatment Approach to Hypertension Based on Concepts of Endothelial Dysfunction and Vascular Biology -- Treatment of Impaired Endothelial Function: A Global CV Approach -- Part 2 What is Hypertension -- Hypothesis: Essential Hypertension and End-Organ Damage -- Hypertension Classification and Guidelines Worldwide -- Hypertension Guidelines -- Global CV Risk Calculation -- Secondary Hypertension -- BP Measurement -- Hypertension8211;Atherosclerotic Syndrome -- Normotensive Hypertension and Hypertension Syndromes -- Prehypertension -- Part 3 Treatment of Hypertension -- Nonpharmacologic Treatment of Hypertension -- Nutrition, Vitamins, Minerals, Antioxidants, Dietary, and Nutraceutical Supplements in the Prevention and Treatment of Hypertension -- Nutritional Intervention, Prevention, and Treatment of Hypertension Trials and Consensus Reports -- Further Reading on Nutrition and Dietary Supplements -- The DASH Diets: DASH-I and DASH-II Sodium -- The Premier Clinical Trial -- Obesity -- Exercise Activities and Kilocalories Used -- Approaches to Selection of Antihypertensive Therapy -- Hemodynamics in Hypertension -- Hemodynamic Effects of Antihypertensive Drugs -- Part 4 Problems Associated with Hypertension -- Hypertension-Related End-Organ Damage -- Life Expectancy and Blood Pressure (Man, 35 Years Old) -- Systolic, Diastolic, and Pulse Pressure Concepts -- Part 5 The Clinical Trials of Hypertension -- Clinical Hypertension Trials and Antihypertensive Drug Therapy -- Treatment of Hypertension: Questions Posed -- Clinical Hypertension Trials: Important Clinical Points -- Diuretic/BB Clinical Trials in Mild-to-Moderate Hypertension and CHD: Summary -- Meta-Analysis of Randomized Controlled Clinical Hypertension Trials with Antihypertensive Drug Therapy -- Meta-Analysis by BP Lowering Treatment Trialists Collaboration -- Staessen, Wang, and Thijs Meta-Analysis: Summary of Clinical Trials in Hypertension and Clinical Outcomes -- Further Reading: Health Outcomes Analysis for Clinical Hypertension Trials -- Combination Meta-Analysis of 354 Randomized Trials -- Prospective Clinical Trials in Hypertension Comparing CCBs to Other Antihypertensive Therapy: Total of 29 Trials -- Clinical Hypertension Trials with CCBs -- SYST-EUR Results -- Conclusions of SYST-EUR Study -- SYST-CHINA Results -- HOT Trial 2 Results -- Results -- INSIGHT -- NORDIL -- CONVINCE -- PREVENT -- VHAS -- PATE -- Incidence of Fatal and Nonfatal CV Events -- ALLHAT -- STOP-2 -- IDNT -- AASK -- ABCD -- ELSA -- INVEST -- SHELL -- MIDAS -- GLANT -- FACET -- ACTION -- ASCOT Clinical Trials: LLA, BPLA, and LLA 2 215; 2 -- ASCOT LLA -- ASCOT BPLA -- ASCOT LLA 2 215; 2 -- VALUE -- BENEDICT -- PHYLLIS -- QUIET -- SCAT -- ADVANCE -- PROTECT -- ANBP-2 -- DIAB-HYCAR -- EUROPA -- HDS -- HYVET -- PART-2 -- PEACE -- CAPPP -- HOPE (Heart Outcomes Prevention Evaluation Study).

Related Book Recommendations